Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H26F3N8O7P |
InChIKeyUCGFIRPRWMWKQG-FQEVSTJZSA-N |
CAS Registry2067281-52-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | United States | - |